Complementation of Der p 2-induced histamine release from human basophils sensitized with monoclonal IgE: Not only by Ige, but also by IgG antibodies directed to a nonoverlapping epitope of Der p 2

Journal of Allergy and Clinical Immunology

Volumn 101, Issue 3, 1998, Pages 404-409

  Schuurman, Janine ^a,b   Perdok, Gerrard J ^a   Mueller, Geoffrey A ^b   Aalberse, Rob C ^c,d  

^a University of Amsterdam ^*

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF VIRGINIA   (United States)

^d CENTRAL LABORATORY   (Netherlands)

Author keywords

Basophil histamine release; Chimeric antibody; Der p 2; IgE; IgG1; IgG4

Indexed keywords

ALLERGEN; DER P 2; DER P 2 ANTIBODY; HISTAMINE; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; RECOMBINANT DER P 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BASOPHIL; GENETIC COMPLEMENTATION; HISTAMINE RELEASE; HUMAN; HUMAN CELL; HYPOTHESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY;

EID: 0031892925     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70255-6     Document Type: Article

References (55)

1. Wasserman SI. Mediators of immediate hypersensitivity. J Allergy Clin Immunol 1983;72:101-15.
2. Segal DM, Taurog JD, Metzger H. Dimeric immunoglobulin E serves as a unit signal for mast cell degranulation. Proc Natl Acad Sci USA 1977;74:2993-7.
3. Fewtrell C, Metzger H. Larger oligomers of IgE are more effective than dimers in stimulating rat basophilic leukemia cells. J Immunol 1980;125:701-10.
4. MacGlashan DW, Schleimer RP, Lichtenstein LM. Qualitative differences between dimeric and trimeric stimulation of human basophils. J Immunol 1983;130:4-6.
5. Kagey-Sobotka A, Dembo M, Goldstein B, Metzger H, Lichtenstein LM. Qualitative characteristics of histamine release from human basophils by covalently cross-linked IgE. J Immunol 1981;127:2285-91.
6. Healicon RM, Foreman JC. Characteristics of histamine release from rat mast cells in relation to the valency of the stimulating ligand. Immunology 1986;57:611-5.
7. Dembo M, Goldstein B, Sobotka AK, Lichtenstein LM. Histamine release due to bivalent penicilloyl haptens: control by the number of cross-linked IgE antibodies on the plasma membrane. J Immunol 1978;121:354-8.
8. Dembo M, Goldstein B, Sobotka AK, Lichtenstein LM. Histamine release due to bivalent penicilloyl haptens: the relation of activation and desensitization of basophils to dynamic aspects of ligand binding to cell surface antibody. J Immunol 1979;122:18-528.
9. Siraganian RP, Hook WA, Levine BB. Specific in vitro histamine release from basophils by bivalent haptens: evidence for activation by simple bridging of membrane bound antibody. Immunochemistry 1975;12:149-57.
10. Mossman H, Meyer-Delius M, Vortisch U, Kickhoefen B, Hammer DK. Experimental studies on the bridging hypothesis of anaphylaxis. Hapten determinants required to elicit immediate-type reactions in calf skin by separate or concurrent sensitization with reagins of different specificity. J Exp Med 1974;140:1468-81.
11. Collins AM, Thelian D, Basil M. Antigen valency as a determinant of the responsiveness of IgE-sensitised rat basophil leukemia cells. Int Arch Allergy Immunol 1995;107:547-56.
12. Sonntag-Nussenzweig R, Merryman C, Benacerraf B. Electrophoretic separation and properties of mouse anti-hapten antibodies involved in passive cutaneous anaphylaxis and passive hemolysis. J Exp Med 1964;120:315-28.
13. Oettgen HC, Martin TR, Wynshaw-Boris A, Deng C, Drazen JM, Leder P. Active anaphylaxis in IgE-deficient mice. Nature 1994;370:367-70.
14. Jimeno L, Lombardero M, Carreira J, Moscoso del Prado J. Presence of IgG4 on the membrane of human basophils. Histamine release is induced by monoclonal antibodies directed against the Fab but not the Fc region of the IgG4 molecule. Clin Exp Allergy 1992;22:1007-14.
15. Vijay HM, Perelmutter L. Inhibition of reagin-mediated PCA reactions in monkeys and histamine release from human leukocytes by human IgG4 subclass. Int Arch Allergy Appl Immunol 1977;53:78-87.
16. Fagan DL, Slaughter CA, Capra JD, Sullivan TJ. Monoclonal antibodies to immunoglobulin G4 induce histamine release from human basophils in vitro. J Allergy Clin Immunol 1982;70:399-404.
17. Van Toorenenbergen AW, Aalberse RC. IgG4 and passive sensitization of basophil leukocytes. Int Arch Allergy Appl Immunol 1981;65:432-40.
18. Van Toorenenbergen AW, Aalberse RC. IgG4 and histamine release from human peripheral blood leukocytes. Int Arch Allergy Appl Immunol 1982;67:117-22.
19. Aalberse RC, Van der Gaag R, Van Leeuwen J. Serological aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4restricted response. J Immunol 1983;130:722-6.
20. Van der Zee JS, Van Swieten P, Aalberse RC. Serological aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency. J Immunol 1986;137:3566-71.
21. Brakenhoff JPJ, De Groot ER, Evers RF, Pannekoek H, Aarden LA. Molecular cloning and expression of hybridoma growth factor in Escherichia coli. J Immunol 1987;139:4116-21.
22. Schuurman J, Lourens TE, Perdok GJ, Parren PWHI, Aalberse RC. Mouse/human chimeric IgE antibodies directed to the house dust mite allergen Der p 2. Int Arch Allergy Immunol 1995;107:465-6.
23. Schuurman J, Perdok GJ, Lourens TE, Parren PWHI, Chapman MD, Aalberse RC. The production of a mouse/human chimeric IgE monoclonal antibody to the house dust mite allergen Der p 2 and its use for the absolute quantification of allergen specific IgE. J Allergy Clin Immunol 1997;99:545-50.
24. Schuurman J, Perdok GJ, Mueller GA, Benjamin DC, Tan KY, Chapman MD, et al. Mouse/human chimeric IgG1 and IgG4 antibodies directed to the house dust mite allergen Der p 2: use in quantification of allergen specific IgG. Clin Exp Allergy 1997;27:1095-102.
25. Ovsyannikova IG, Vailes LD, Li Y, Heymann PW, Chapman MD. Monoclonal antibodies to group II Dermatophagoides spp. allergens: murine immune response, epitope analysis, and development of a two-site ELISA. J Allergy Clin Immunol 1994;94:537-46.
26. Van der Zee JS, Van Swieten P, Jansen HM, Aalberse RC. Skin tests and histamine release with PI-depleted D. pteronyssinus body extracts and purified PI. J Allergy Clin Immunol 1988;81:884-96.
27. Orlandi R, Guessow DH, Jones PT, Winter G. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc Natl Acad Sci USA 1989;86:3833-7.
28. Schuurman J, Perdok GJ, Aalberse RC. Mouse/human chimeric antibodies directed to two non-overlapping epitopes of the house dust mite allergen Der p 2. Int Arch Allergy Immunol 1997;113:262-3.
29. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning, a laboratory manual. New York: Cold Spring Harbor Laboratory Press; 1989.
30. Mulligan RC, Berg P. Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase. Proc Natl Acad Sci USA 1981;78:2972-2076.
31. Mulligan RC, Berg P. Expression of a bacterial gene in mammalian cells. Science 1980;209:1422-7.
32. Brueggemann M, Williams GT, Bindon CI, Clark MR, Walker MR, Jetteris R, et al. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med 1987;166:1351-61.
33. Parren PWHI, Geerts MEJ, Boeije LCM, Aarden LA. Induction of T-cell proliferation by recombinant mouse and chimeric mouse/human anti-CD3 monoclonal antibodies. Res Immunol 1991;142:749-63.
34. Flanagan JG, Rabbitts TH. The sequence of a human immunoglobulin epsilon heavy chain constant region gene, and evidence for three non-allelic genes. EMBO J 1982;1:655-60.
35. Neuberger MS, Williams GT, Mitchell EB, Jouhal SS, Flanagan JG, Rabbitts TH. A hapten-specific chimaeric IgE antibody with human physiological effector function. Nature 1985;314:268-70.
36. Takahashi N, Ueda S, Obata M, Nikaido T, Nakai S, Honjo T. Structure of human immunoglobulin gamma genes: implications for evolution of a gene family. Cell 1982;29:671-9.
37. Southern PJ, Berg P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promotor. J Mol Appl Genet 1982;1:327-41.
38. Pruzansky JJ, Grammer LC, Patterson R, Roberts M. Dissociation of IgE from receptors on human basophils. I. Enhanced passive sensitization for histamine release. J Immunol 1983;131:1949-53.
39. Pasmans SGMA, Witteman AM, Aalbers M, Boonstra JG, Mul FPJ, Vander Zee JS, et al. Variability of IgE-dependent histaminereleasing activity in supernatants of human mononuclear cells. Int Arch Allergy Immunol 1994;103:44-52.
40. Levy DA, Osler AG. Studies on the mechanisms of hypersensitivity phenomena XIV. Passive sensitization in vitro of human leukocytes to ragweed pollen antigen. J Immunol 1966;97:203-12.
41. Bazaral M, Hamburger RN. Standardization and stability of immunoglobulin E (IgE). J Allergy Clin Immunol 1972;49:189-91.
42. Knol EF, Kuijpers TW, Mul FPJ, Roos D. Stimulation of human basophils results in homotypic aggregation: a response independent of degranulation. J Immunol 1993;151:4926-33.
43. Siraganian R. Refinements in the automated fluorometric histamine analysis system. J Immunol Methods 1975;7:282-90.
44. Mueller GA, Smith AM, Williams DC, Hakkaart SAJ, Aalberse RC, Chapman MD, et al. Expression and secondary structure determination by NMR methods of the major house dust mite allergen Der p 2. J Biol Chem 1997;272:26893-8.
45. Daeron M, Malbec O, Latour S, Arock M, Fridman WH. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J Clin Invest 1995;95:577-85.
46. Van de Winkel JGJ, Capel PJA. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today 1993;14:215-21.
47. Schumacher MJ, Jeffery SE. Effect of quantity and quality of IgG antibodies on blocking of allergenic histamine release in vitro. Int Arch Allergy Appl Immunol 1979;58:38-43.
48. May CD, Lyman MS, Alberto R, Aduna N. On the measurement of blocking antibody. J Allergy Clin Immunol 1972;49:54-8.
49. Kemeny DM, Kagey-Sobotka A, Lichtenstein LM, Lessof MH. IgE and IgG antibody response to purified bee-venom antigens and peptides in four patients who had adverse reactions to immunotherapy. Clin Allergy 1988;18:79-84.
50. Clinton PM, Kemeny DM, Youlten LJF, Lessof MH. Histamine release from peripheral blood leukocytes with purified bee venom allergens: effect of hyperimmune beekeeper plasma. Int Arch Allergy Appl Immunol 1989;89:43-8.
51. Lambin P, Bouzoumou A, Murrieta M, Debbia M, Rouger P, Leynadier F, et al. Purification of human IgG4 subclass with allergen-specific blocking activity. J Immunol Methods 1993;165:99111.
52. Van der Giessen M, Homan WL, Van Kernebeek G, Aalberse RC, Dieges PH. Subclass typing of IgG antibodies formed by grass pollen-allergic patients during immunotherapy. Int Arch Allergy Appl Immunol 1976;50:625-40.
53. Van Metre TE, Marsh DG, Adkinson NF, Kagey-Sobotka A, Khattignavong A, Norman PS, et al. Immunotherapy decreases skin sensitivity to cat extract. J Allergy Clin Immunol 1989;83:888-99.
54. Witteman AM, Stapel SO, Sjamsoedin DHS, Jansen HM, Aalberse RC, Van der Zee JS. Fei d 1-specific IgG antibodies induced by natural exposure have blocking activity in skin tests. Int Arch Allergy Immunol 1996;109:369-75.
55. Phillips ML, Tao M-H, Morrison SL, Schumaker VN. Human/mouse chimeric monoclonal antibodies with human IgG1, IgG2, IgG3 and IgG4 constant domains: electron microscopic and hydrodynamic characterization. Mol Immunol 1994;31:1201-10.